Literature DB >> 13233347

The effect of phenylbutazone on uric acid metabolism in two normal subjects.

J B WYNGAARDEN.   

Abstract

Entities:  

Keywords:  ANALGESICS/effects; URIC ACID/metabolism

Mesh:

Substances:

Year:  1955        PMID: 13233347      PMCID: PMC438622          DOI: 10.1172/JCI103078

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  17 in total

1.  Uricolysis in normal man.

Authors:  J B WYNGAARDEN; D STETTEN
Journal:  J Biol Chem       Date:  1953-07       Impact factor: 5.157

2.  A new method for preparing a highly purified uricase suitable for uric acid determination by ultraviolet spectrophotometry.

Authors:  A F MULLER; W BAUER
Journal:  J Lab Clin Med       Date:  1953-03

3.  Current therapy of gout.

Authors:  C J SMYTH
Journal:  J Am Med Assoc       Date:  1953-07-18

4.  Effect of phenylbutazone on uric acid excretion in patients with gout and rheumatoid arthritis.

Authors:  C BISHOP; L BEECHER
Journal:  Proc Soc Exp Biol Med       Date:  1953-07

5.  Current principles of management in gout.

Authors:  A B GUTMAN; T F YU
Journal:  Am J Med       Date:  1952-12       Impact factor: 4.965

6.  Recovery in humans of intravenously injected isotopic uric acid.

Authors:  J BUZARD; C BISHOP; J H TALBOTT
Journal:  J Biol Chem       Date:  1952-05       Impact factor: 5.157

7.  The effect of butazolidin (phenylbutazone) on water and electrolyte excretion.

Authors:  E L WILKINSON; H BROWN
Journal:  Am J Med Sci       Date:  1953-02       Impact factor: 2.378

8.  Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects.

Authors:  T F YU; J H SIROTA; A B GUTMAN
Journal:  J Clin Invest       Date:  1953-11       Impact factor: 14.808

9.  Phenylbutazone (butazolidin) and butapyrin; a study of clinical effects in arthritis and gout.

Authors:  W C KUZELL; R W SCHAFFARZICK
Journal:  Calif Med       Date:  1952-11

10.  Clinical studies of phenylbutazone (butazolidin) and butapyrin (irgapyrin) in rheumatoid arthritis, rheumatoid spondylitis, and gout.

Authors:  E G KIDD; K C BOYCE; R H FREYBERG
Journal:  Ann Rheum Dis       Date:  1953-03       Impact factor: 19.103

View more
  4 in total

1.  The uricosuria and orotic aciduria induced by 6-azauridine.

Authors:  H J FALLON; E FREI; J BLOCK; J E SEEGMILLER
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

2.  Evaluation of uricosuric agents in chronic gout.

Authors:  M A OGRYZLO; J HARRISON
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

3.  Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent.

Authors:  T F YU; B C PATON; T CHENKIN; J J BURNS; B B BRODIE; A B GUTMAN
Journal:  J Clin Invest       Date:  1956-04       Impact factor: 14.808

4.  [Effect of benzbromaronum on the renal uric acid excretion in healthy persons].

Authors:  N Zöllner; W Dofel; W Gröbner
Journal:  Klin Wochenschr       Date:  1970-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.